Document is current
Any future updates will be listed below
-
Authors
Cacciamani, Federica
Sambati, Luisa
Houot, Marion
Habert, Marie-Odile
Dubois, Bruno
Epelbaum, Stéphane http://orcid.org/0000-0003-4059-2891
,
Audrain, C.
Auffret, A.
Bakardjian, H.
Baldacci, F.
Batrancourt, B.
Benakki, I.
Benali, H.
Bertin, H.
Bertrand, A.
Boukadida, L.
Cacciamani, F.
Causse, V.
Cavedo, E.
Cherif Touil, S.
Chiesa, P. A.
Colliot, O.
Dalla Barba, G.
Depaulis, M.
Dos Santos, A.
Dubois, B.
Dubois, M.
Epelbaum, S.
Fontaine, B.
Francisque, H.
Gagliardi, G.
Genin, A.
Genthon, R.
Glasman, P.
Gombert, F.
Habert, M. O.
Hampel, H.
Hewa, H.
Houot, M.
Jungalee, N.
Kas, A.
Kilani, M.
La Corte, V.
Le Roy, F.
Lehericy, S.
Letondor, C.
Levy, M.
Lista, S.
Lowrey, M.
Ly, J.
Makiese, O.
Masetti, I.
Mendes, A.
Metzinger, C.
Michon, A.
Mochel, F.
Nait Arab, R.
Nyasse, F.
Perrin, C.
Poirier, F.
Poisson, C.
Potier, M. C.
Ratovohery, S.
Revillon, M.
Rojkova, K.
Santos-Andrade, K.
Schindler, R.
Servera, M. C.
Seux, L.
Simon, V.
Skovronsky, D.
Thiebaut, M.
Uspenskaya, O.
Vlaincu, M.
- License Information
-
More Information
Article History
Received: 28 July 2020
Accepted: 1 October 2020
First Online: 14 October 2020
Ethics approval and consent to participate
: Each participant of the INSIGHT-PreAD cohort signed an informed consent, and Paris VI ethical committee approved the study protocol.
: Not applicable
: Federica Cacciamani reports no disclosures.Luisa Sambati reports no disclosures.Marion Houot reports no disclosures.Marie-Odile Habert has received speaker honoraria from Lilly, GE Healthcare, and Piramal.Bruno Dubois has received consultancy fees from Biogen, Boehringer Ingelheim, Eli Lilly, and MedAvante and grants for his institution from Merck, Pfizer, and Roche.Stéphane Epelbaum reports receiving fees from Roche, Eli Lilly, Biogen, and GE Healthcare as a consultant or advisory board member.
